Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients - Gallego-Escuredo, J M; Gómez-Ambrosi, J; Catalan, V; Domingo, P; Giralt, M; Frühbeck, G; Villarroya, F (International Journal of Obesity, 2015)
Keywords: 692/53; 692/699/2743/137/773; 692/699/2743/393; Abnormalities; Adipose tissue; Adipose Tissue - metabolism; Adult; Body Mass Index; Body size; Correlation; Development and progression; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Enzyme-linked immunosorbent assay; Epidemiology; Female; Fibroblast growth factor receptor 1; Fibroblast growth factor receptors; Fibroblast Growth Factors - metabolism; Gene expression; Genetic aspects; Genetic research; Glucose; Glucose tolerance; Glucose Tolerance Test; Growth factors; Health Promotion and Disease Prevention; Homeostasis; Humans; Immunoblotting; Insulin; Insulin Resistance; Internal Medicine; Klotho protein; Liver; Liver - metabolism; Male; Medicine; Medicine & Public Health; Membrane Proteins - metabolism; Metabolic Diseases; Metabolic syndrome; Obesity; Obesity - metabolism; original-article; Polymerase chain reaction; Properties; Proteins; Public Health; Receptors; Receptors, Fibroblast Growth Factor - metabolism; Reverse transcription; Rodents; Serum levels; Signal Transduction; Spain; Thinness - metabolism; Triglycerides; Weight control; Spain